Product Information

MEMANTINE-DONEPEZIL ER 28-10 MG is a generic product labeled by Vitruvias Therapeutics Inc., priced at $7.7913 per EA under NDC 69680018530. Its NADAC has been published 62 times since Sep 10, 2025.

FDA first approved this application on Jul 15, 2025. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

MEMANTINE-DONEPEZIL ER 28-10 MG

memantine hydrochloride and donepezil hydrochloride
$7.7913per EA

Strength

10; 28 mg/1; mg/1

NDC

69680018530

Classification

Generic

Dosage Form

CAPSULE, EXTENDED RELEASE

Route

ORAL

Effective Date

10/21/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA216901

FDA Approved

7/15/2025

TE Code

AB

On Market Since

7/16/2025

Pharmacological Classes

Cholinesterase Inhibitor
Cholinesterase Inhibitors
N-methyl-D-aspartate Receptor Antagonist
NMDA Receptor Antagonists

Price Statistics

The NADAC for MEMANTINE-DONEPEZIL ER 28-10 MG has been published 62 times since Sep 10, 2025, and over the history we have for it it has declined 55.9%. The table below summarizes its recorded NADAC range and movement.

Current price$7.7913 per EA
All-time high$17.6769 (Sep 10, 2025)
All-time low$7.7913 (Oct 21, 2026)
52-week high$16.2193
52-week low$7.7913
Median price$13.9386
Average price$13.2088
Largest weekly change-10.6% (Sep 23, 2026)
Weeks tracked62
Tracking sinceSep 10, 2025

Price History

1W

0.0%

1M

-7.7%

3M

-24.1%

6M

-38.7%

1Y

-53.2%

3Y

N/A

5Y

N/A

All

-55.9%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of MEMANTINE-DONEPEZIL ER 28-10 MG?

The current National Average Drug Acquisition Cost (NADAC) for MEMANTINE-DONEPEZIL ER 28-10 MG, manufactured by Vitruvias Therapeutics Inc., is $7.7913 per EA (NDC 69680018530), effective Nov 11, 2026.

How has the price of MEMANTINE-DONEPEZIL ER 28-10 MG changed over time?

Over the history we have for it, the NADAC for MEMANTINE-DONEPEZIL ER 28-10 MG has declined 55.9%. It has been tracked across 62 weekly CMS publications since Sep 10, 2025.

What are the highest and lowest recorded NADAC prices for MEMANTINE-DONEPEZIL ER 28-10 MG?

Since Sep 10, 2025, the NADAC for MEMANTINE-DONEPEZIL ER 28-10 MG has ranged from a low of $7.7913 (Oct 21, 2026) to a high of $17.6769 (Sep 10, 2025), with a median of $13.9386 per EA.

Are there cheaper alternatives to MEMANTINE-DONEPEZIL ER 28-10 MG?

1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as MEMANTINE-DONEPEZIL ER 28-10 MG in a comparable dosage form, but none are currently priced below it.

Who manufactures MEMANTINE-DONEPEZIL ER 28-10 MG?

MEMANTINE-DONEPEZIL ER 28-10 MG (NDC 69680018530) is labeled by Vitruvias Therapeutics Inc., and CMS classifies it as a generic product.